Find a pharmacy Healthcare professionals Partnering Press TR EN RU AR
My Product Is Safe Enter the batch number on your product to reach its production and expiry dates.
Contact
Tablets on the conveyor of a solid dosage manufacturing line
Since 1989 · Ankara

The manufacturing behind access to medicines in Türkiye.

We have been manufacturing in Ankara since 1989. Six medicines authorised in Türkiye and nine marketing authorisation applications, across five therapy areas — principally urology, nephrology and immunology.

Our pipeline Our medicines
MedicinesProduct information, SmPC and package leaflet → Consumer healthOur food supplement products → Report a side effectSpeak to your doctor or pharmacist first →
Aymed at a glance

We keep a small portfolio and a growing pipeline.

0
medicines authorised and marketed in Türkiye
0
marketing authorisation applications under way
500 g – 500 kg
batch size range at a single site
0%
of the electricity used at our site comes from our rooftop solar plant
Our therapy areas

We work in five therapy areas and build depth in each of them.

Our medicines and our marketing authorisation applications are concentrated in five therapy areas. Select an area to see the work under way there.

Urology

Authorised medicines

    Marketing authorisation applications

      Aymed İlaç manufacturing site: the building and entrance facade at Başkent OSB
      Aymed İlaç has operated in Ankara since 1989.
      About us

      Access to medicines guides how we choose our development programmes.

      We have been manufacturing in Ankara since 1989. Today, with more than 100 employees, a manufacturing site holding a GMP certificate issued by TİTCK and a growing pipeline, we are a manufacturer focused on a small number of therapy areas within the Turkish pharmaceutical industry. Bringing medicines that were not previously available in Türkiye to the Turkish market through domestic manufacturing has been our core business since the company was founded.

      1989founded
      100+employees
      2sites · Ankara
      My Product Is Safe

      See the production record of the pack in your hand.

      By scanning the code on your product with your phone or entering it manually, you can reach that batch’s production date, expiry date and directions for use.

      The look-up applies to our authorised products on the market. No app download, registration or personal detail is required. No personal data is collected during the query.

      See how it works →
      1 · ScanScan the data matrix code on the pack with your phone camera.
      2 · See the batchThe production date and time, batch number and expiry date appear on screen.
      3 · See the directionsThe directions for using the product are displayed.
      For healthcare professionals and partners

      The sections below describe our development pipeline and contract manufacturing services. Information addressed to consumers is in the sections above.

      Research and development

      What is next in our pipeline?

      9marketing authorisation applications
      2with a Phase 3 programme under way
      7under regulatory review

      Note: The products in this section are at the development and marketing authorisation stage. None of them is authorised yet and none is available on the market.

      Which areas are the applications in?

      • 3Immunology
      • 2Oncology and haematology
      • 2Nephrology
      • 1Urology
      • 1Metabolic and rare diseases
      >
      Solar power plant panels on the roof of the manufacturing site
      Contract development and manufacturing

      We take on commercial manufacturing for products that have completed development, and formulation development on a project basis. Much of the electricity used in our production comes from renewable sources.

      Every step from granulation to packaging is carried out at our site in Ankara, and the same equipment train runs from a 500-gram development trial to a 500-kilogram final blend. About half of the electricity used at the site is generated by the solar plant on our roof; on-site generation lowers the emissions attributable to production here, which customers working with supplier-specific data can reflect in their own Scope 3 category 1 reporting.

      Capability information for business partners. Not an offer.

      50%of site electricity from solar
      Capability Matrix

      Which services do we provide for which dosage forms?

      Find the dosage form in the row and the service in the column. Click a cell for the detail. All capabilities are described on the Manufacturing and Quality Capabilities page.

      Contract manufacturing capabilities by dosage form and service
      Select a cell

      Click the cell where a dosage form meets a service to see the capability detail.

      Request a proposal
      ● full capability◐ project based– out of scope
      Press Room

      News from the company

      Multi-counting system and line operator on the bottle filling line

      Our AYM-B02 and AYM-B03 programmes reached Phase 3

      Clinical development has reached Phase 3 in two of our biological product programmes in immunology.

      Read more →
      Capsule packaging on the blister line

      Bioequivalence studies completed in five programmes

      Bioequivalence studies have been completed for the AYM-201, AYM-202, AYM-204, AYM-205 and AYM-206 programmes; stability studies are ongoing.

      Read more →
      Solar panels on the manufacturing site roof

      Our rooftop solar plant completed its first full year

      Over a one-year period, about half of our production electricity came from the rooftop panels.

      Read more →
      Careers

      Making medicines is teamwork.

      Open positions

      Let us talk about working together.

      Contact us